Indivior (LON:INDV) Shares Up 11.9% – Time to Buy?

Indivior PLC (LON:INDV)’s share price was up 11.9% during trading on Thursday . The stock traded as high as GBX 738 ($9.58) and last traded at GBX 731 ($9.49). Approximately 231,070 shares traded hands during trading, a decline of 82% from the average daily volume of 1,264,178 shares. The stock had previously closed at GBX 653.50 ($8.48).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,500 ($19.48) price objective on shares of Indivior in a report on Thursday, September 5th.

Indivior Trading Up 1.2 %

The stock has a market capitalization of £898.84 million, a P/E ratio of -873.75, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The stock’s fifty day moving average price is GBX 768.73 and its two-hundred day moving average price is GBX 1,080.23. The company has a current ratio of 0.85, a quick ratio of 1.52 and a debt-to-equity ratio of 2,790.00.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.